Evidence map›Paper›PMID 18728638›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2008

Whole animal in vivo imaging after transient, nonviral gene delivery to the rat central nervous system.

Ellen S Hauck, Shaomin Zou, Keith Scarfo, Michael H Nantz, James G Hecker

Open access · greenAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Intrathecal drug delivery in the era of nanomedicine.Advanced drug delivery reviews · 2020
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Nucleophilic cationization reagents.Tetrahedron letters · 2010
    Article
  10. Antioxidant enzyme gene transfer for ischemic diseases.Advanced drug delivery reviews · 2009
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ellen S HauckDepartment of Anesthesia, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6112, USA.
Shaomin Zou
Keith Scarfo
Michael H Nantz
James G Hecker
University of Pennsylvania · USUniversity of Louisville · US

Funding

Non-viral controllable gene delivery for neuroprotectionR01NS046591 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI HECKER, JAMES GORDON · 2003 to 2007
$1.7M
NONVIRAL GENE TRANSFER FOR CNS NEUROPROTECTIONK08NS001960 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI HECKER, JAMES GORDON · 1999 to 2003
$550k
NINDS NIH HHS K08 NS001960NINDS NIH HHS R01 NS046591
6 · The paper itself

Abstract

We previously showed that a vector:lipid delivery system, comprised of a plasmid DNA vector and cationic lipid (lipoplex), when injected into the cerebrospinal fluid (CSF) of rats can deliver reporter genes in vivo efficiently and with widespread expression to the Central Nervous System (CNS). To further characterize this delivery system, we now present experiments that demonstrate the in vivo time-to-peak expression of the reporter gene, firefly luciferase. We infused a formulated lipoplex containing the lipid MLRI [dissymmetric myristoyl (14:0) and lauroyl (12:1) rosenthal inhibitor-substituted compound formed from the tetraalkylammonium glycerol-based DORI] and pNDluc, a luciferase vector, into CSF in the cisterna magna (CM) of the rat. Luciferase activity was followed over time by bioluminescence imaging after injection of luciferin. Our results show that luciferase activity in the CNS of rats is widespread, peaks 72 hours after injection into CM and can be detected in vivo for at least 7-10 days after peak expression. We further show that in contrast to injection into CSF, enzyme activity is not widely distributed after injection of the vector into brain parenchyma, emphasizing the importance of CSF delivery to achieve widespread vector distribution. Finally, we confirm the distribution of firefly luciferase in brain by immunohistochemical staining from an animal that was euthanized at the peak of enzyme expression.

Indexed as

AnimalsBrainCell LineCentral Nervous SystemCisterna MagnaDrug CarriersGenes, ReporterGene Transfer TechniquesLipidsLuciferases, FireflyMaleRatsRats, Sprague-DawleyDrug CarriersLipidsLuciferases, Firefly

Identifiers

PMID18728638
PMCPMC2575133
OpenAlexW2088624985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.